"In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.

Black women Community-engaged research Health disparities Latinas Leiomyomas Menstruation Taboo Uterine fibroids Women’s health

Journal

BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690

Informations de publication

Date de publication:
12 Apr 2024
Historique:
received: 24 12 2022
accepted: 28 02 2024
medline: 13 4 2024
pubmed: 13 4 2024
entrez: 12 4 2024
Statut: epublish

Résumé

Uterine fibroids are non-cancerous neoplasms that arise from the uterus affecting over 75% of women. However, there is a disparity with Black women having an increased prevalence of nearly 80%. Black women also experience increased symptom burden, including younger age at the time of diagnosis and increased number and volume of fibroids. Less is known about other ethnoracially diverse women such as Latinas and the potential cultural impacts on fibroid burden and treatment. Community engagement studios were conducted to facilitate discussions with stakeholders on their uterine fibroid and menstruation experience. We recruited Black women (n = 6) diagnosed with uterine fibroids and Latinas (n = 7) without uterine fibroids. We held two virtual community engagement studios split by uterine fibroid diagnosis. The studios were not audio recorded and notes were taken by four notetakers. The notes were thematically analyzed in Atlas.ti using content analysis. Participants felt there was a lack of discussion around menstruation overall, whether in the home or school settings. This lack of menstruation education was pronounced when participants had their first menstruation experience, with many unaware of what to expect. This silence around menstruation led to a normalization of painful menstruation symptoms. When it came to different treatment options for uterine fibroids, some women wanted to explore alternative treatments but were dismissed by their healthcare providers. Many participants advocated for having discussions with their healthcare provider about life goals to discuss different treatment options for their uterine fibroids. Despite uterine fibroid diagnosis, there is silence around menstruation. Menstruation is a normal biological occurrence and needs to be discussed to help prevent delayed diagnosis of uterine fibroids and possibly other gynecological disorders. Along with increased discussions around menstruation, further discussion is needed between healthcare providers and uterine fibroid patients to explore appropriate treatment options.

Sections du résumé

BACKGROUND BACKGROUND
Uterine fibroids are non-cancerous neoplasms that arise from the uterus affecting over 75% of women. However, there is a disparity with Black women having an increased prevalence of nearly 80%. Black women also experience increased symptom burden, including younger age at the time of diagnosis and increased number and volume of fibroids. Less is known about other ethnoracially diverse women such as Latinas and the potential cultural impacts on fibroid burden and treatment.
METHODS METHODS
Community engagement studios were conducted to facilitate discussions with stakeholders on their uterine fibroid and menstruation experience. We recruited Black women (n = 6) diagnosed with uterine fibroids and Latinas (n = 7) without uterine fibroids. We held two virtual community engagement studios split by uterine fibroid diagnosis. The studios were not audio recorded and notes were taken by four notetakers. The notes were thematically analyzed in Atlas.ti using content analysis.
RESULTS RESULTS
Participants felt there was a lack of discussion around menstruation overall, whether in the home or school settings. This lack of menstruation education was pronounced when participants had their first menstruation experience, with many unaware of what to expect. This silence around menstruation led to a normalization of painful menstruation symptoms. When it came to different treatment options for uterine fibroids, some women wanted to explore alternative treatments but were dismissed by their healthcare providers. Many participants advocated for having discussions with their healthcare provider about life goals to discuss different treatment options for their uterine fibroids.
CONCLUSION CONCLUSIONS
Despite uterine fibroid diagnosis, there is silence around menstruation. Menstruation is a normal biological occurrence and needs to be discussed to help prevent delayed diagnosis of uterine fibroids and possibly other gynecological disorders. Along with increased discussions around menstruation, further discussion is needed between healthcare providers and uterine fibroid patients to explore appropriate treatment options.

Identifiants

pubmed: 38610011
doi: 10.1186/s12905-024-03008-z
pii: 10.1186/s12905-024-03008-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

233

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR002380
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002380
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Stewart EA, Nowak RA. Uterine fibroids: hiding in Plain Sight. Physiology. 2021;37(1):16–27.
doi: 10.1152/physiol.00013.2021 pmcid: 8742728
Marsh E, Al-Hendy A, Kappus D, Galitsky A, Stewart E, Kerolous M. Burden, Prevalence, and treatment of uterine fibroids: a Survey of U.S. women. J Womens Health (Larchmt). 2018;27(11):1359–67.
doi: 10.1089/jwh.2018.7076 pubmed: 30230950
Orellana M, Riggan KA, Dsouza K, Stewart EA, Venable S, Balls-Berry JE, Allyse MA. Perceptions of Ethnoracial factors in the management and treatment of uterine fibroids. J Racial Ethnic Health Disparities. 2021;9(4):1184–91.
doi: 10.1007/s40615-021-01059-8
DSouza KN, Riggan KA, Orellana M, Venable S, Stewart EA, Balls-Berry JE, Allyse MA. Experiences of women desiring pregnancy following uterine fibroid diagnosis. J Reprod Med. 2021;66(7–8):169–75.
Stewart E, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG: Int J Obstet Gynecol. 2017;124(10):1501–12.
doi: 10.1111/1471-0528.14640
Wise LA, Laughlin-Tommaso SK. Epidemiology of uterine fibroids: from Menarche to Menopause. Clin Obstet Gynecol. 2016;59(1):2–24.
doi: 10.1097/GRF.0000000000000164 pubmed: 26744813 pmcid: 4733579
Klatsky P, Tran N, Caughey A, Fujimoto V. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008;198(4):357–66.
doi: 10.1016/j.ajog.2007.12.039 pubmed: 18395031
Laughlin-Tommaso S, Jacoby V, Myers E. Disparities in fibroid incidence, prognosis, and management. Obstet Gynecol Clin North Am. 2017;44(1):81–94.
doi: 10.1016/j.ogc.2016.11.007 pubmed: 28160895
Berman JM, Bradley L, Hawkins SM, Levy B. Uterine fibroids in Black women: a race-stratified subgroup analysis of treatment outcomes after laparoscopic Radiofrequency ablation. J Women’s Health. 2021;31(4):593–9.
doi: 10.1089/jwh.2020.9001
Orellana M, Riggan KA, K DS, Stewart EA, Venable S, Balls-Berry JE, Allyse MA. Perceptions of Ethnoracial factors in the management and treatment of uterine fibroids. J Racial Ethn Health Disparities. 2022;9(4):1184–91.
doi: 10.1007/s40615-021-01059-8 pubmed: 34013445
Wechter ME, Stewart EA, Myers ER, Kho RM, Wu JM. Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends. Am J Obstet Gynecol. 2011;205(5):492e1–5.
doi: 10.1016/j.ajog.2011.07.008
Stewart E, Nicholson W, Bradley L, Borah B. The burden of uterine fibroids for African-American women: results of a national survey. J Womens Health (Larchmt). 2013;22(10):807–16.
doi: 10.1089/jwh.2013.4334 pubmed: 24033092
Hakim R, Benedict M, Merrick N. Quality of care for women undergoing a hysterectomy: effects of insurance and race/ethnicity. Am J Public Health. 2004;94(8):1399–405.
doi: 10.2105/AJPH.94.8.1399 pubmed: 15284050 pmcid: 1448462
Manuel EC, Plowden TC, Valbuena FM, Bryce RL, Barick AA, Ramakrishnan A, et al. The Environment, Leiomyomas, Latinas, and Adiposity Study: rationale and design. American Journal of Obstetrics and Gynecology; 2021.
Sekula NM, Plowden TC, Waldo A, Bryce R, Castillo-Mackenzie M, Acosta S et al. Getting the Word Out: methods of learning about Research and motivations for participation in a study focusing on a Reproductive aged Latina/x Population. J Clin Translational Sci. 2022:1–21.
Borah B, Nicholson W, Bradley L, Stewart E. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209(4):319. .e1–.e20
doi: 10.1016/j.ajog.2013.07.017 pmcid: 4167669
Riggan KA, Stewart EA, Balls-Berry JE, Venable S, Allyse MA. Patient recommendations for Shared decision-making in uterine fibroid treatment decisions. J Patient Experience. 2021;8:23743735211049655.
doi: 10.1177/23743735211049655
Joosten YA, Israel TL, Williams NA, Boone LR, Schlundt DG, Mouton CP, et al. Community Engagement studios: a Structured Approach to obtaining Meaningful Input from stakeholders to inform Research. Acad Medicine: J Association Am Med Colleges. 2015;90(12):1646–50.
doi: 10.1097/ACM.0000000000000794
Rimer BK, Glanz K, National Cancer I. Theory at a glance: a guide for health promotion practice. 2005.
Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11(1):1–47.
doi: 10.1177/109019818401100101 pubmed: 6392204
Miles M, Huberman M, Saldaña J. Qualitative Data Analysis: A Methods Sourcebook2013.
Hsieh H, Shannon S. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.
doi: 10.1177/1049732305276687 pubmed: 16204405
Saldana J. The Coding Manual for qualitative researchers. SAGE; 2021.
Costos D, Ackerman R, Paradis L. Recollections of Menarche: communication between mothers and daughters regarding menstruation. Sex Roles. 2002;46(1):49–59.
doi: 10.1023/A:1016037618567
Hawkey AJ, Ussher JM, Perz J. I treat my daughters not like my mother treated me: migrant and Refugee women’s Constructions and experiences of Menarche and Menstruation. In: Bobel C, Winkler IT, Fahs B, Hasson KA, Kissling EA, Roberts T-A, editors. The Palgrave Handbook of critical menstruation studies. Singapore: Springer Singapore; 2020. pp. 99–113.
doi: 10.1007/978-981-15-0614-7_10
Rierdan J, Koff E, Flaherty J. Conceptions and misconceptions of menstruation. Women Health. 1986;10(4):33–45.
doi: 10.1300/J013v10n04_04
Schmitt ML, Hagstrom C, Nowara A, Gruer C, Adenu-Mensah NE, Keeley K, Sommer M. The intersection of menstruation, school and family: experiences of girls growing up in urban areas in the U.S.A. Int J Adolescence Youth. 2021;26(1):94–109.
doi: 10.1080/02673843.2020.1867207
Rubinsky V, Gunning JN, Cooke-Jackson A. I thought I was dying: (Un)supportive communication surrounding early menstruation experiences. Health Commun. 2020;35(2):242–52.
doi: 10.1080/10410236.2018.1548337 pubmed: 30460861
Hennegan J, Winkler IT, Bobel C, Keiser D, Hampton J, Larsson G, et al. Menstrual health: a definition for policy, practice, and research. Sex Reproductive Health Matters. 2021;29(1):1911618.
DeMaria AL, Delay C, Sundstrom B, PhD MPH, Wakefield AL, Naoum ZM, Ramos-Ortiz J, et al. My mama told me it would happen: menarche and menstruation experiences across generations. Women Health. 2020;60(1):87–98.
doi: 10.1080/03630242.2019.1610827 pubmed: 31023171
Casola AR, Kunes B, Jefferson K, Riley AH. Menstrual Health Stigma in the United States: communication complexities and implications for theory and practice. Journal of Midwifery & Women’s Health. 2021;n/a(n/a).
Sommer M, Ackatia-Armah N, Connolly S, Smiles D. A comparison of the menstruation and education experiences of girls in Tanzania, Ghana, Cambodia and Ethiopia. Compare: J Comp Int Educ. 2015;45(4):589–609.
doi: 10.1080/03057925.2013.871399
Stubbs ML. Cultural perceptions and practices around Menarche and adolescent menstruation in the United States. Ann N Y Acad Sci. 2008;1135(1):58–66.
doi: 10.1196/annals.1429.008 pubmed: 18574209
Munro MG. Abnormal Uterine Bleeding. 1st ed: Cambridge University Press; 2010 February 8, 2010.
Tan DA, Haththotuwa R, Fraser IS. Cultural aspects and mythologies surrounding menstruation and abnormal uterine bleeding. Best Pract Res Clin Obstet Gynecol. 2017;40:121–33.
doi: 10.1016/j.bpobgyn.2016.09.015
Pao PS. Social Stigma Centred around Menstruation: A Reflective Review. 2023:51 – 8.
Gottlieb A. Menstrual Taboos: Moving Beyond the Curse. 2020. p. 143 – 61.
Ghant MS, Sengoba KS, Vogelzang R, Lawson AK, Marsh EE. An altered perception of normal: understanding causes for treatment Delay in Women with symptomatic uterine fibroids. J Womens Health (Larchmt). 2016;25(8):846–52.
doi: 10.1089/jwh.2015.5531 pubmed: 27195902
National Institute for Health and Care Excellence. : Clinical Guidelines. Heavy menstrual bleeding: assessment and management. London: National Institute for Health and Care Excellence (NICE). Copyright © NICE 2021.; 2021.
Vannuccini S, Jain V, Critchley H, Petraglia F. From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health. Fertil Steril. 2022;118(4):625–36.
doi: 10.1016/j.fertnstert.2022.07.021 pubmed: 36075746
Critchley HOD, Babayev E, Bulun SE, Clark S, Garcia-Grau I, Gregersen PK, et al. Menstruation: science and society. Am J Obstet Gynecol. 2020;223(5):624–64.
doi: 10.1016/j.ajog.2020.06.004 pubmed: 32707266 pmcid: 7661839
Sekula N, Jiang C, Malone A, Caldwell MT, Wise LA, Marsh EE, RACIAL AND SOCIOECONOMIC DISPARITIES IN 2019 EMERGENCY DEPARTMENT UTILIZATION FOR FIBROIDS IN THE UNITED STATES. Fertil Steril. 2022;118(4):e367.
doi: 10.1016/j.fertnstert.2022.09.190
Thompson T-aM, Young Y-Y, Bass TM, Baker S, Njoku O, Norwood J, Simpson M. Racism runs through it: examining the sexual and Reproductive Health experience of Black women in the South. Health Aff. 2022;41(2):195–202.
doi: 10.1377/hlthaff.2021.01422
VanNoy BN, Bowleg L, Marfori C, Moawad G, Zota AR. Black women’s Psychosocial experiences with seeking Surgical Treatment for Uterine fibroids: implications for clinical practice. Women’s Health Issues. 2021;31(3):263–70.
doi: 10.1016/j.whi.2021.01.001 pubmed: 33610438 pmcid: 9835088
Baird D, Dunson D, Hill M, Cousins D, Schectman J. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.
doi: 10.1067/mob.2003.99 pubmed: 12548202
Marshall L, Spiegelman D, Barbieri R, Goldman M, Manson J, Colditz G, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90(6):967–73.
doi: 10.1016/S0029-7844(97)00534-6 pubmed: 9397113
Powell L, Meyer P, Weiss G, Matthews K, Santoro N, Randolph J, et al. Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues. 2005;15(4):179–86.
doi: 10.1016/j.whi.2005.05.002 pubmed: 16051109
Wegienka G, Stewart EA, Nicholson WK, Zhang S, Li F, Thomas L, et al. Black women are more likely Than White women to schedule a uterine-sparing treatment for Leiomyomas. J Womens Health (Larchmt). 2021;30(3):355–66.
doi: 10.1089/jwh.2020.8634 pubmed: 33524308
Scalia P, Durand M, Forcino R, Schubbe D, Barr P, O’Brien N, et al. Implementation of the uterine fibroids option Grid patient decision aids across five organizational settings: a randomized stepped-wedge study protocol. Implement Sci. 2019;14(1):88.
doi: 10.1186/s13012-019-0933-z pubmed: 31477140 pmcid: 6721118
Doll KM, Snyder CR, Ford CL. Endometrial cancer disparities: a race-conscious critique of the literature. Am J Obstet Gynecol. 2018;218(5):474–82e2.
doi: 10.1016/j.ajog.2017.09.016 pubmed: 28964822

Auteurs

Minerva Orellana (M)

Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.

Karen N DSouza (KN)

Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA.

Jane Q Yap (JQ)

Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Abhirami Sriganeshan (A)

University of Miami, Miami, FL, USA.

M Elena Jones (ME)

Department of Neurology, Washington University School of Medicine, 4488 Forest Park, St. Louis, MO, 63108, USA.

Charis Johnson (C)

Department of Neurology, Washington University School of Medicine, 4488 Forest Park, St. Louis, MO, 63108, USA.

Megan Allyse (M)

Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Program in Biomedical Ethics Research, Mayo Clinic, Rochester, MN, USA.
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.

Sateria Venable (S)

The Fibroid Foundation, Bethesda, MD, USA.

Elizabeth A Stewart (EA)

Division of Reproductive Endocrinology, Department of Obstetrics & Gynecology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic College of Medicine & Science, Rochester, MN, USA.

Felicity Enders (F)

Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic College of Medicine & Science, Rochester, MN, USA.
Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.

Joyce E Balls-Berry (JE)

Department of Neurology, Washington University School of Medicine, 4488 Forest Park, St. Louis, MO, 63108, USA. j.balls-berry@wustl.edu.

Classifications MeSH